Skip to content
value.today
Total raised
$221 M
4 rounds on record
Latest round
$37 M
Oct 2022
First round on record
May 2019
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of MycoWorks, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Oct 2022$37 MNo. 4$10 to $50 million

MycoWorks, Inc.: Raise no. 4, Oct 2022

Investors in this round

11 investors had bought by the notice of Jun 16, 2023: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$37 M of $63 M offered; $26 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Matthew Scullin · Executive Officer, Director
  • Gaetano Crupi · Director
  • Kiersten Stead · Director
  • Patrick Thomas · Director
  • Stephen van Helden · Director
  • Tjerk de Ruiter · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Matthew Scullin, Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 16, 2023. Read the notice at the SEC.

equitySEC
Jan 2022$125 MNo. 3$50 to $250 million

MycoWorks, Inc.: Raise no. 3, Jan 2022

Investors in this round

17 investors had bought by the notice of Apr 4, 2022: 17 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$125 M of $125 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Matthew Scullin · Executive Officer, Director
  • Anders Bendsen Spohr · Director
  • Kiersten Stead · Director
  • Patrick de Thomas · Director
  • Tjerk de Ruiter · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Matthew Scullin, Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 4, 2022. Read the notice at the SEC.

equitySEC
Oct 2020$45 MNo. 2$10 to $50 million

MycoWorks, Inc.: Raise no. 2, Oct 2020

Investors in this round

32 investors had bought by the notice of Nov 16, 2021: 32 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$45 M of $45 M offered
Smallest investment taken
no minimum stated
What was sold
equity, debt
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Matthew Scullin · Executive Officer, Director
  • Michael Lindheim · Executive Officer
  • Kiersten Stead · Director
  • Philip Ross · Director
  • Thomas Grotkjaer · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Michael Lindheim, Chief Operating Officer. Source: SEC Form D, newest notice filed Nov 16, 2021. Read the notice at the SEC.

equity, debtSEC
May 2019$14 MNo. 1$10 to $50 million

MycoWorks, Inc.: Raise no. 1, May 2019

Investors in this round

31 investors had bought by the notice of Nov 16, 2021: 31 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$14 M of $14 M offered
Smallest investment taken
no minimum stated
What was sold
equity, debt
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Matthew Scullin · Executive Officer, Director
  • Michael Lindheim · Executive Officer
  • Chris Hill · Director
  • Philip Ross · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Michael Lindheim, Chief Operating Officer. Source: SEC Form D, newest notice filed Nov 16, 2021. Read the notice at the SEC.

equity, debtSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • MycoWorks, Inc. chose not to state its revenue in its newest notice of a funding round (Jun 2023).

    SEC Form D · Jun 2023

  • The industry group it chose in its notices: Other.

    SEC Form D · Jun 2023

That is all the official record says: MycoWorks, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of MycoWorks, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 32 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by MycoWorks, Inc.
NameRoleNamed in
Matthew ScullinExecutive officerJun 2023
Michael LindheimExecutive officerNov 2021
Gaetano CrupiDirectorJun 2023
Kiersten SteadDirectorJun 2023
Matthew ScullinDirectorJun 2023
Patrick ThomasDirectorJun 2023
Stephen van HeldenDirectorJun 2023
Tjerk de RuiterDirectorJun 2023
Anders Bendsen SpohrDirectorApr 2022
Patrick de ThomasDirectorApr 2022
Chris HillDirectorNov 2021
Philip RossDirectorNov 2021
Thomas GrotkjaerDirectorNov 2021